The different manifestations (Table 5.13) of Type I depend on the degree of
previous exposure to the allergen and also on the route of exposure. The
underlying cause is the production of IgE in response to an allergen. This type
of antibody stimulates inflammatory responses that are aimed at eliminating
parasitic worms. Atopic individuals produce IgE in response to allergens
that, in nonallergic individuals, would stimulate the production of IgG. The
tissue mast cells and blood basophils have receptors for the Fc region of
IgE, so that IgE binds to the surface of these cells. The more sensitized an
individual, the more their mast cells are coated with IgE. Further exposure to
the same allergen results in the cross-linking of mast-cell bound IgE by the
allergen (Figure 5.10). This triggers an explosive degranulation of the mast
cell that releases pharmacologically active mediators, including histamine,
which causes vasodilation, smooth muscle contraction and mucus secretion,
depending on where they are released. In addition the subsequent release
of further mediators, for example leukotrienes and prostaglandins, which
are synthesized at the mast cell membrane potentiate inflammation and
smooth muscle contraction. This response which evolved as a defense
against multicellular parasites, causes the characteristic symptoms of the
hypersensitivity.
IMMUNOLOGICAL HYPERSENSITIVITYCZhhVg6]bZY!BVjgZZc9Vlhdc!8]g^hHb^i]:YLddY &&.
Disorder EffectsAllergic rhinitis (hay fever) seen in upper respiratory tract; excess mucus; sneezing and
wheezingAtopic eczema extensive and very itchy rash in skin; a common manifestation
in atopic childrenFood allergies skin rash (hives); gastrointestinal ‘cramps’ and diarrhea; may
sometimes result in anaphylactic shockAllergic asthma severe inflammation in respiratory tract; severe respiratory
distressAnaphylactic shock sudden drop in blood pressure; respiratory distress; skin rash;
gastrointestinal ‘cramps’ and diarrhea; may result in death
within an hour of exposureDrug allergies, e.g. penicillin,
sulphonamides, salicylatesmay be trivial (as in skin rash) or severe, as in anaphylactic
shockTable 5.13Manifestations of Type I hypersensitivity
Type Names Examples of disorder Immune system
component involvedI immediate; anaphylactic hay fever; allergic asthma;
food allergies; anaphylactic
shockIgEII cytotoxic transfusion reactions;
hemolytic disease of the
newborn (HDN)IgM, IgG and complementIII complex-mediated intrinsic allergic alveolitis;
serum sicknessantigen/antibody complexes
(usually IgG )IV delayed-type
hypersensitivity (DTH)Mantoux reaction; contact
hypersensitivitysensitized CD4+
T lymphocytesTable 5.12The Gell and Coombs classification of immunological hypersensitivity
SS SS
SSSS SS
SSSS SS
SSSS SS
SSSSSSSSExposure to
allergenIgEIgE binds to receptors on
mast cells and basophilsSubsequent
exposure to
allergenAllergen
cross-links
IgE
moleculesDegranulation of
mast cells and
basophilsRelease of mediators of
inflammationFigure 5.10 Schematic illustrating how exposure
to an allergen can lead to degranulation of mast
cells and basophils and Type I hypersensitivity.